Trial Profile
Gabapentin in Functional Dyspepsia Refractory to Proton Pump Inhibition
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase III
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Gabapentin (Primary)
- Indications Non-ulcer dyspepsia
- Focus Therapeutic Use
- 30 Sep 2020 Planned End Date changed from 1 May 2011 to 28 Aug 2012.
- 30 Sep 2020 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 24 Jan 2010 New trial record